Houghton PJ. The biological activity of Valerian and related plants.
J Ethnopharmacol. 1988;22:121 - 142.
Krieglstein J, Grusla D. Centrally depressant components of valerian. However, valepotriates, valerenic acid, valeranone and the essential oil are ineffective [in German].
Dtsch Apoth Ztg. 1988;128:2041 - 2046.
Santos MS, Ferreira F, Cunha AP, et al. Synaptosomal GABA release as influenced by valerian root extract - involvement of the GABA carrier.
Arch Int Pharmacodyn Ther. 1994;327:220 - 231.
Santos MS, Ferreira F, Cunha AP, et al. An aqueous extract of valerian influences the transport of GABA in synaptosomes.
Planta Med. 1994;60:278 - 279.
Holzl J, Godau P. Receptor bindings studies with
Valeriana officinalis
on the benzodiazepine receptor.
Planta Médica. 1989;55:642.
Mennini T, Bernasconi P, Bombardelli E, et al. In vitro study on the interaction of extracts and pure compounds from
Valeriana officinalis
roots with GABA, benzodiazepine, and barbiturate receptors in rat brain.
Fitoterapia. 1993;64:291 - 300.
Santos MS, Ferreira F, Faro C, et al. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [
3H
] GABA release in synaptosomes.
Planta Med. 1994;60:475 - 476.
Cavadas C, Arajo I, Cotrim MD, et al. In vitro study on the interaction of
Valeriana officinalis
L. extracts and their amino acids on GABAa receptor in rat brain.
Arzneimittelforschung. 1995;45:753 - 755.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:81.
Vorbach EU, Gortelmeyer R, Bruning J. Therapy for insomniacs: effectiveness and tolerance of valerian preparations [translated from German].
Psychopharmakotherapie. 1996;3:109 - 115.
Leathwood PD, Chauffard F, Heck E, et al. Aqueous extract of valerian root (
Valeriana officinalis
L.) improves sleep quality in man.
Pharmacol Biochem Behav. 1982;17:65 - 71.
Kamm-Kohl AV, Jansen W, Brockmann P. Modern valerian therapy for nervous disorders in old age [translated from German].
Med Welt. 1984;35:1450 - 1454.
Dorn M. Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study [translated from German].
Forsch Komplementarmed Klass Naturheilkd. 2000;7:79 - 84.
Schmitz M, Jackel M. Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug [translated from German].
Wien Med Wochenschr. 1998;148:291 - 298.
Cerny A, Schmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study).
Fitoterapia.
1999;70:221 - 228.
Dressing H, Riemann D, Low H, et al. Insomnia: are valerian/balm combinations of equal value to benzodiazepine [translated from German]?
Therapiewoche. 1992;42:726 - 736.
Kohnen R, Oswald WD. The effects of valerian, propranolol, and their combination on activation, performance and mood of healthy volunteers under social stress conditions.
Pharmacopsychiatry. 1988;21:447 - 448.
Cropley M, Cave Z. Effect of kava and valerian on physiological responses to psychological stress assessed under laboratory conditions [abstract].
FACT. 2001;6:76.
Hendriks H, Bos R, Woerdenbag HJ, et al. Central nervous depressant activity of valerenic acid in the mouse.
Planta Med. 1985;1:28 - 31.
Leuschner J, Muller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract.
Arzneimittelforschung. 1993;43:638 - 641.
Krieglstein J, Grusla D. Centrally depressant components of valerian. However, valepotriates, valerenic acid, valeranone and the essential oil are ineffective [in German].
Dtsch Apoth Ztg. 1988;128:2041 - 2046.
European Scientific Cooperative on Phytotherapy.
Valerianae radix. Exeter, UK: ESCOP; 1996-1997:3 - 4. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:77,81.
European Scientific Cooperative on Phytotherapy.
Valerianae radix. Exeter, UK: ESCOP; 1996-1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Rosecrans JA, Defeo JJ, Youngken HW Jr. Pharmacological investigation of certain
Valeriana officinalis
L. extracts.
J Pharm Sci. 1961;50:240 - 244.
Willey LB, Mady SP, Cobaugh DJ, et al. Valerian overdose: a case report.
Vet Hum Toxicol. 1995;37:364 - 365.
MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies.
BMJ.
1989;299:1156 - 1157.
Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian).
Postgrad Med J.
1995;71(834):227 - 228.
Chan TY. An assessment of the delayed effects associated with valerian overdose [letter].
Int J Clin Pharmacol Ther.
1998;36:569.
Tyler VE.
Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: Pharmaceutical Products Press; 1994:118.
European Scientific Cooperative on Phytotherapy.
Valerianae radix. Exeter, UK: ESCOP; 1996-1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal.
JAMA.
1998;280:1566 - 1567.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:77,81.
Vorbach EU, Gortelmeyer R, Bruning J. Therapy for insomniacs: effectiveness and tolerance of valerian preparations [translated from German].
Psychopharmakotherapie. 1996;3:109 - 115.
Albrecht M, Berger W, Laux P, et al. Psychopharmaceuticals and safety in traffic. [translated from German].
Z Allgemeinmed. 1995;71:1215 - 1225.
Gerhard U, Linnenbrink N, Georghiadou C, et al. Vigilance-decreasing effects of 2 plant-derived sedatives.
Schweiz Rundsch Med Prax. 1996;85:473 - 481.
European Scientific Cooperative on Phytotherapy.
Valerianae radix. Exeter, UK: ESCOP; 1996 - 1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Kuhlmann J, Berger W, Podzuweit H, et al. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers.
Pharmacopsychiatry.
1999;32:235 - 241.
European Scientific Cooperative on Phytotherapy.
Valerianae radix. Exeter, UK: ESCOP; 1996 - 1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Albrecht M, Berger W, Laux P, et al. Psychopharmaceuticals and safety in traffic. [translated from German].
Z Allgemeinmed. 1995;71:1215 - 1225.
Sakamoto T, Mitani Y, Nakajima K. Psychotropic effects of Japanese valerian root extract.
Chem Pharm Bull (Tokyo). 1992;40:758 - 761.
Rosecrans JA, Defeo JJ, Youngken HW Jr. Pharmacological investigation of certain
Valeriana officinalis
L. extracts.
J Pharm Sci. 1961;50:240 - 244.
Poyares DR, Guilleminault C, Ohayon MM, Tufik S. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:539 - 545.
Andreatini R, Sartori VA, Seabra ML, et al. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
Phytother Res. 2002;16:650 - 654.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.